DIFFUSION PHARMACEUTICALS IN (DFFN)

US2537484048 - Common Stock

4.4  +0.46 (+11.68%)

After market: 4.46 +0.06 (+1.36%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
13.73M15.97M16.04M15.97M11.55M
Research and Development
4.08M7.24M8.50M9.43M6.62M
Selling, General, and Administrative Expenses
9.65M8.74M7.45M6.44M4.83M
Operating Income
-13.73M-15.97M-16.04M-15.97M-11.55M
Interest Income/Expense
650.93K380.75K137.49K114.26K90.00K
Other Income/Expense
N/AN/AN/AN/AN/A
Non Recurring Items
N/A0.00-8.64MN/A0.00
Income Before Taxes
-13.08M-15.59M-24.54M-15.86M-11.47M
Income Tax
N/A0.00-443.89K-1.68M330.00K
Net Income
-13.08M-15.59M-24.10M-16.14M-11.80M
EBITDA
N/AN/A-15.94M-15.87M-11.45M
 
Per Share Data
EPS Diluted Total Ops
-6.41-7.65-12.34-14.99-1.76
Non GAAP EPS
N/AN/A-8.50-13.00-107.50
 
Statistics

All data in USD

Charts